Rev1 Ventures garners $15 mln for sophomore fund

Rev1 Ventures has raised $15 million for its second fund focused on life science companies.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this